REPORT ID 2127

Asia-Pacific Spine Biologics Market Report 2019

Publish Date
2019
Pages
118
Format
Electronic (PDF)

In this report, the Asia-Pacific Spine Biologics market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Spine Biologics for these regions, from   2019 to 2025 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Spine Biologics market competition by top manufacturers/players, with Spine Biologics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Zimmer Holding
    Depuy Synthes
    Medtronic(U.S.)
    Nuvasive
    Stryker Corporation
    Orthofix International
    K2M
    Exactech
    Wright Medical Technology
    Nutech
    Arthrex
    X-Spine Systems(Bacterin International Holdings)
    DR PRP USA
    Alphatec spine
    Life Spine

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Bone Graft
    Bine Graft Substitute
    Platelet Rich Plasma
    BMAC

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Spine Biologics for each application, includin
    Anterior Cervical Discectomy and Fusion
    Posterior Lumbar Interbody Fusion

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Asia-Pacific Spine Biologics Market  Report 2019
1 Spine Biologics Overview
    1.1 Product Overview and Scope of Spine Biologics
    1.2 Classification of Spine Biologics by Product Category
        1.2.1 Asia-Pacific Spine Biologics Market Size (Sales) Comparison by Types ( 2014-2024)
        1.2.2 Asia-Pacific Spine Biologics Market Size (Sales) Market Share by Type (Product Category)  in 2018
        1.2.3 Bone Graft
        1.2.4 Bine Graft Substitute
        1.2.5 Platelet Rich Plasma
        1.2.6 BMAC
    1.3 Asia-Pacific Spine Biologics Market by Application/End Users
        1.3.1 Asia-Pacific Spine Biologics Sales (Volume) and Market Share Comparison by Applications ( 2014-2024)
        1.3.2 Anterior Cervical Discectomy and Fusion
        1.3.3 Posterior Lumbar Interbody Fusion
    1.4 Asia-Pacific Spine Biologics Market by Region
        1.4.1 Asia-Pacific Spine Biologics Market Size (Value) Comparison by Region ( 2014-2024)
        1.4.2 China Status and Prospect ( 2014-2024)
        1.4.3 Japan Status and Prospect ( 2014-2024)
        1.4.4 South Korea Status and Prospect ( 2014-2024)
        1.4.5 Taiwan Status and Prospect ( 2014-2024)
        1.4.6 India Status and Prospect ( 2014-2024)
        1.4.7 Southeast Asia Status and Prospect ( 2014-2024)
        1.4.8 Australia Status and Prospect ( 2014-2024)
    1.5 Asia-Pacific Market Size (Value and Volume) of Spine Biologics ( 2014-2024)
        1.5.1 Asia-Pacific Spine Biologics Sales and Growth Rate ( 2014-2024)
        1.5.2 Asia-Pacific Spine Biologics Revenue and Growth Rate ( 2014-2024)

2 Asia-Pacific Spine Biologics Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Spine Biologics Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Spine Biologics Sales Volume and Market Share of Key Players/Suppliers ( 2014-2019)
        2.1.2 Asia-Pacific Spine Biologics Revenue and Share by Players/Suppliers ( 2014-2019)
    2.2 Asia-Pacific Spine Biologics (Volume and Value) by Type
        2.2.1 Asia-Pacific Spine Biologics Sales and Market Share by Type ( 2014-2019)
        2.2.2 Asia-Pacific Spine Biologics Revenue and Market Share by Type ( 2014-2019)
    2.3 Asia-Pacific Spine Biologics (Volume) by Application
    2.4 Asia-Pacific Spine Biologics (Volume and Value) by Region
        2.4.1 Asia-Pacific Spine Biologics Sales and Market Share by Region ( 2014-2019)
        2.4.2 Asia-Pacific Spine Biologics Revenue and Market Share by Region ( 2014-2019)

3 China Spine Biologics (Volume, Value and Sales Price)
    3.1 China Spine Biologics Sales and Value ( 2014-2019)
        3.1.1 China Spine Biologics Sales Volume and Growth Rate ( 2014-2019)
        3.1.2 China Spine Biologics Revenue and Growth Rate ( 2014-2019)
        3.1.3 China Spine Biologics Sales Price Trend ( 2014-2019)
    3.2 China Spine Biologics Sales Volume and Market Share by Type
    3.3 China Spine Biologics Sales Volume and Market Share by Application

4 Japan Spine Biologics (Volume, Value and Sales Price)
    4.1 Japan Spine Biologics Sales and Value ( 2014-2019)
        4.1.1 Japan Spine Biologics Sales Volume and Growth Rate ( 2014-2019)
        4.1.2 Japan Spine Biologics Revenue and Growth Rate ( 2014-2019)
        4.1.3 Japan Spine Biologics Sales Price Trend ( 2014-2019)
    4.2 Japan Spine Biologics Sales Volume and Market Share by Type
    4.3 Japan Spine Biologics Sales Volume and Market Share by Application

5 South Korea Spine Biologics (Volume, Value and Sales Price)
    5.1 South Korea Spine Biologics Sales and Value ( 2014-2019)
        5.1.1 South Korea Spine Biologics Sales Volume and Growth Rate ( 2014-2019)
        5.1.2 South Korea Spine Biologics Revenue and Growth Rate ( 2014-2019)
        5.1.3 South Korea Spine Biologics Sales Price Trend ( 2014-2019)
    5.2 South Korea Spine Biologics Sales Volume and Market Share by Type
    5.3 South Korea Spine Biologics Sales Volume and Market Share by Application

6 Taiwan Spine Biologics (Volume, Value and Sales Price)
    6.1 Taiwan Spine Biologics Sales and Value ( 2014-2019)
        6.1.1 Taiwan Spine Biologics Sales Volume and Growth Rate ( 2014-2019)
        6.1.2 Taiwan Spine Biologics Revenue and Growth Rate ( 2014-2019)
        6.1.3 Taiwan Spine Biologics Sales Price Trend ( 2014-2019)
    6.2 Taiwan Spine Biologics Sales Volume and Market Share by Type
    6.3 Taiwan Spine Biologics Sales Volume and Market Share by Application

7 India Spine Biologics (Volume, Value and Sales Price)
    7.1 India Spine Biologics Sales and Value ( 2014-2019)
        7.1.1 India Spine Biologics Sales Volume and Growth Rate ( 2014-2019)
        7.1.2 India Spine Biologics Revenue and Growth Rate ( 2014-2019)
        7.1.3 India Spine Biologics Sales Price Trend ( 2014-2019)
    7.2 India Spine Biologics Sales Volume and Market Share by Type
    7.3 India Spine Biologics Sales Volume and Market Share by Application

8 Southeast Asia Spine Biologics (Volume, Value and Sales Price)
    8.1 Southeast Asia Spine Biologics Sales and Value ( 2014-2019)
        8.1.1 Southeast Asia Spine Biologics Sales Volume and Growth Rate ( 2014-2019)
        8.1.2 Southeast Asia Spine Biologics Revenue and Growth Rate ( 2014-2019)
        8.1.3 Southeast Asia Spine Biologics Sales Price Trend ( 2014-2019)
    8.2 Southeast Asia Spine Biologics Sales Volume and Market Share by Type
    8.3 Southeast Asia Spine Biologics Sales Volume and Market Share by Application

9 Australia Spine Biologics (Volume, Value and Sales Price)
    9.1 Australia Spine Biologics Sales and Value ( 2014-2019)
        9.1.1 Australia Spine Biologics Sales Volume and Growth Rate ( 2014-2019)
        9.1.2 Australia Spine Biologics Revenue and Growth Rate ( 2014-2019)
        9.1.3 Australia Spine Biologics Sales Price Trend ( 2014-2019)
    9.2 Australia Spine Biologics Sales Volume and Market Share by Type
    9.3 Australia Spine Biologics Sales Volume and Market Share by Application

10 Asia-Pacific Spine Biologics Players/Suppliers Profiles and Sales Data
    10.1 Zimmer Holding
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Spine Biologics Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 Zimmer Holding Spine Biologics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.1.4 Main Business/Business Overview
    10.2 Depuy Synthes
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Spine Biologics Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 Depuy Synthes Spine Biologics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.2.4 Main Business/Business Overview
    10.3 Medtronic(U.S.)
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Spine Biologics Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 Medtronic(U.S.) Spine Biologics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.3.4 Main Business/Business Overview
    10.4 Nuvasive
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Spine Biologics Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 Nuvasive Spine Biologics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.4.4 Main Business/Business Overview
    10.5 Stryker Corporation
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Spine Biologics Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 Stryker Corporation Spine Biologics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.5.4 Main Business/Business Overview
    10.6 Orthofix International
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Spine Biologics Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 Orthofix International Spine Biologics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.6.4 Main Business/Business Overview
    10.7 K2M
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Spine Biologics Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 K2M Spine Biologics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.7.4 Main Business/Business Overview
    10.8 Exactech
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 Spine Biologics Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 Exactech Spine Biologics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.8.4 Main Business/Business Overview
    10.9 Wright Medical Technology
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 Spine Biologics Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 Wright Medical Technology Spine Biologics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.9.4 Main Business/Business Overview
    10.10 Nutech
        10.10.1 Company Basic Information, Manufacturing Base and Competitors
        10.10.2 Spine Biologics Product Category, Application and Specification
            10.10.2.1 Product A
            10.10.2.2 Product B
        10.10.3 Nutech Spine Biologics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.10.4 Main Business/Business Overview
    10.11 Arthrex
    10.12 X-Spine Systems(Bacterin International Holdings)
    10.13 DR PRP USA
    10.14 Alphatec spine
    10.15 Life Spine

11 Spine Biologics Manufacturing Cost Analysis
    11.1 Spine Biologics Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Spine Biologics

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Spine Biologics Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Spine Biologics Major Manufacturers  in 2018
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Spine Biologics Market Forecast ( 2019-2025)
    15.1 Asia-Pacific Spine Biologics Sales Volume, Revenue and Price Forecast ( 2019-2025)
        15.1.1 Asia-Pacific Spine Biologics Sales Volume and Growth Rate Forecast ( 2019-2025)
        15.1.2 Asia-Pacific Spine Biologics Revenue and Growth Rate Forecast ( 2019-2025)
        15.1.3 Asia-Pacific Spine Biologics Price and Trend Forecast ( 2019-2025)
    15.2 Asia-Pacific Spine Biologics Sales Volume, Revenue and Growth Rate Forecast by Region ( 2019-2025)
        15.2.1 Asia-Pacific Spine Biologics Sales Volume and Growth Rate Forecast by Region ( 2019-2025)
        15.2.2 Asia-Pacific Spine Biologics Revenue and Growth Rate Forecast by Region ( 2019-2025)
        15.2.3 China Spine Biologics Sales, Revenue and Growth Rate Forecast ( 2019-2025)
        15.2.4 Japan Spine Biologics Sales, Revenue and Growth Rate Forecast ( 2019-2025)
        15.2.5 South Korea Spine Biologics Sales, Revenue and Growth Rate Forecast ( 2019-2025)
        15.2.6 Taiwan Spine Biologics Sales, Revenue and Growth Rate Forecast ( 2019-2025)
        15.2.7 India Spine Biologics Sales, Revenue and Growth Rate Forecast ( 2019-2025)
        15.2.8 Southeast Asia Spine Biologics Sales, Revenue and Growth Rate Forecast ( 2019-2025)
        15.2.9 Australia Spine Biologics Sales, Revenue and Growth Rate Forecast ( 2019-2025)
    15.3 Asia-Pacific Spine Biologics Sales, Revenue and Price Forecast by Type ( 2019-2025)
        15.3.1 Asia-Pacific Spine Biologics Sales Forecast by Type ( 2019-2025)
        15.3.2 Asia-Pacific Spine Biologics Revenue Forecast by Type ( 2019-2025)
        15.3.3 Asia-Pacific Spine Biologics Price Forecast by Type ( 2019-2025)
    15.4 Asia-Pacific Spine Biologics Sales Forecast by Application ( 2019-2025)

16 Research Findings and Conclusion

17 Appendix
    17.1 Methodology/Research Approach
        17.1.1 Research Programs/Design
        17.1.2 Market Size Estimation
        17.1.3 Market Breakdown and Data Triangulation
    17.2 Data Source
        17.2.1 Secondary Sources
        17.2.2 Primary Sources
    17.3 Disclaimer